Early CRP kinetics predict long-term treatment success and favorable outcomes of anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma (2022) Klümper N, Sikic D, Saal J, Buettner T, Jarczyk J, Zeuschner P, Weinke M, et al. Conference contribution Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy (2022) Hecht M, Eckstein M, Kallies A, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution, Abstract of a poster A prospective, open-label, multicenter, randomized phase II trial: Sequential therapy with BEvacizumab, RAd001 (Everolimus) and AxiTinib in metastatic renal cell carcinoma (mRCC) (BERAT study of the IAG-N) (2022) Hilser T, Gruenwald V, Bergmann L, Goebell P, Strauss A, Meiler J, Hartmann A, et al. Conference contribution Prognostic potential of baseline HRQoL in advanced and metastatic renal cell carcinoma (2022) Gruenwald V, Goebell P, Schostak M, Welslau M, Doehn C, Degenkolbe E, Ehness R, et al. Conference contribution Clinical and histopathological characterization of penile carcinomas with focus on HPV-status and histological subtype (2022) Mink J, Khalmurzaev O, Hoelters S, Pryalukhin A, Heinzelbecker J, Lohse S, Bende K, et al. Conference contribution Multicentric validation of a comprehensive geriatric assessment to predict functional outcome and mortality following urooncological operations (2022) Fiebig C, Kahlmeyer A, Bannert H, Taubert H, Wach S, Koneval L, Graf S, et al. Conference contribution Interprofessional Communication about Complementary and Integrative Health (CIH): Development and Implementation of a Training Program (2022) Behzad A, Stein B, Kaltenbach A, Lohmueller L, Kroeger B, Boltenhagen U, Joos S, et al. Conference contribution Recapitulating Drug Treatment in a Dish - Investigating the Impact of 2D Versus 3D In Vitro Cancer Models and Different Treatment Schemes on Drug Response (2022) Sankarasubramanian S, Kroger AC, Pfohl U, Loskutov J, Linnebacher M, Regenbrecht C, Regenbrecht C, Wedeken L Conference contribution Meeting Medical Need - Development of a High-Throughput Assay Using Pancreatic Cancer Patient Derived Organoids as a Tool for Personalized Medicine (2022) Sankarasubramanian S, Niethard M, Pilarsky C, Regenbrecht C, Wedeken L Conference contribution Introducing SKINFO - the new and unique web-based information platform for German-speaking skin cancer patients (2022) Steeb T, Hoffmann J, Meier F, Weber C, Bergmann M, Mueller-Schuchardt A, Weiler N, et al. Conference contribution